Latest News


Understanding DNA Methylation Tests and How to Use Them for Cancer Screening

The rise of epigenetics has brought to light the potential of DNA methylation tests in the early detection and prognosis of various types of cancers. In this article, we delve into the process of DNA methylation, how it affects cancer development, and how tests that detect this epigenetic change can be utilized for effective cancer screening. We’ll also introduce you to some innovative products from a leading Chinese manufacturer and supplier, Wuhan Ammunition Life-tech Co., Ltd (WALT), that utilize this technology for early cancer detection.

What is DNA Methylation?

DNA methylation is a biochemical process where a methyl group is added to a DNA molecule. This process can alter the activity of a DNA segment without changing its sequence. When located in a gene promoter, DNA methylation typically acts to repress gene transcription, influencing gene expression and affecting various cellular processes.

DNA Methylation and Cancer

Abnormal DNA methylation patterns have been associated with several types of cancers. For instance, hypermethylation (excessive methylation) of tumor suppressor genes can lead to their inactivation, promoting tumor growth. Conversely, hypomethylation (insufficient methylation) can lead to overactivity of certain genes, including oncogenes. Monitoring these methylation changes can provide valuable insights for cancer screening, diagnosis, and treatment.

DNA Methylation Tests for Cancer Screening

DNA methylation tests can detect these abnormal patterns in DNA from various sources like blood, stool, or tissue samples. Among the most innovative of these tests are those developed by WALT, a high-tech enterprise focusing on early, non-invasive detection products for high-incidence malignant tumors.

WALT’s DNA Methylation Detection Kits

WALT offers a series of DNA Methylation Detection Kits for various types of cancers. These kits use Real-Time PCR technology to accurately detect changes in DNA methylation associated with specific types of cancer, providing a non-invasive, convenient, and promising method for early cancer detection.

  1. The ICervsure kit is designed for the detection of cervical cancer.
  2. The IColocomf and IColohunter kits focus on colorectal cancer, using stool DNA and plasma DNA, respectively.
  3. The IEsohunter kit is used for esophageal cancer detection.
  4. The IHepcomf kit is designed to detect liver cancer.
  5. The IUterusure kit is used for endometrial cancer detection.

Each of these kits offers a non-invasive, efficient method for early cancer detection, contributing to improved patient prognosis and survival rates.

Why Choose WALT?

Established in January 2015, WALT has quickly become a leading figure in the field of early non-invasive detection products for high-incidence malignant tumors. Their commitment to saving lives by providing cutting-edge diagnosis products is reflected in their innovative DNA methylation detection kits. With a keen focus on quality management, WALT’s products have been approved by ISO13485 and passed on-site audits from various clients. Learn more about WALT and their groundbreaking products.

In conclusion, DNA methylation tests provide a promising avenue for the early detection of various types of cancers. As research advances and technologies like those offered by WALT become more refined and accessible, we can look forward to a future where early cancer detection is the norm, not the exception.

For more information on cancer screening, check out our blog post on bowel cancer screening.

Inquiry Now

Contact Us Right Now